Diabetes Market Research Reports & Industry Analysis

Amid the COVID-19 crisis, the global diabetes insulin delivery pen market size is expected to grow from an estimated value of USD 16,975 million in 2022 to USD 22,170 million by 2028. After conducting...

This report can be delivered to the clients within 72 Business Hours Diabetes Associated Ophthalmic Treatment Market Growth & Trends The global diabetes associated ophthalmic treatment market size i...

Outlook of Diabetic Macular Edema – Current Landscape and the Way Forward: LONG-LASTING VEGF BLOCKERS, COMPOUNDS WITH VEGF- INDEPENDENT MECHANISM AND, TOPICAL AND ORAL TREATMENT OPTIONS, BRING THE QUE...

The global digital diabetes management market is growing at a CAGR of over 18% during the forecast period 2018–2024. The global digital diabetes management market has witnessed significant growth in s...

... treatment therapies for diabetes and a strict regulatory framework that hamper the growth of the global type 2 diabetes market. Based on the region, the global type 2 diabetes ... of the World. North America dominates the global type 2 diabetes market owing to technological advancements and supportive government ...

“Diabetic Foot Ulcer (DFU) Pipeline Analysis” gives comprehensive insights on the various drugs being developed for the treatment of DFU. The ... research for DFU. Market Data Forecasting model for DFU market DFU market dynamics DFU Market Sizing DFU related deals & Funding scenario in DFU market Pipeline Analysis ...

Global Diabetic Neuropathy Market to reach USD 8460.3 million by 2025. Global Diabetic Neuropathy Market valued approximately USD 4680 million in 2016 is ... Target Audience of the Global Diabetic Neuropathy Market in Market Study: Key Consulting Companies & Advisors Large, medium-sized, and small enterprises ...

... skin irritation due to frequent use of needles. The U.S. next generation diabetes therapy and drug delivery market is segmented based on product type, ... analysis of the key developments in the industry. The U.S. next generation diabetes therapy and drug delivery market is comprehensively analyzed with respect to ...

... for the manufacturers of human insulin. Market Analysis: The “Global Human Insulin” market is estimated to witness a CAGR of 10.2% during the forecast period 2017–2023. The human insulin market is analyzed based on three ...

... within 20 years. Market Analysis According to Infoholic Research, the “Global Artificial Intelligence in Diabetes Management” market is expected to grow at a CAGR of 50.7% ... Benefits The study covers and analyzes the “Global Artificial Intelligence in Diabetes Management” market. Bringing out the complete key ...

... the market leader In the EU5, several of the Type 2 Diabetes Mellitus medical affairs teams we surveyed are running neck and neck with ... ways you can improve your medical affair services in Medical Affairs Reputations: Type 2 Diabetes Mellitus (Orals) (EU5). Comparing 9 major Type 2 Diabetes Mellitus (Orals) ...

... the ways you can improve your medical affairs services in Medical Affairs Reputations: Type 2 Diabetes Mellitus (Orals) (US). Comparing 9 major oral Type 2 Diabetes Mellitus treatments from AstraZeneca ...

... still maintained a relatively optimistic growth, the past four years, Diabetes market size to maintain the average annual growth rate of 1.96% from 401 ... ) Channel (Direct Sales, Distributor) Segmentation Section 7: 400 USD - Trend (2017-2021) Section 8: 300 USD - Product Type Detail Section 9: 700 ...

... does each of the leading brands compare to its competitors? NPS+ Type 2 Diabetes Mellitus (EU5) gives a unique insight into the overall brand health ... degludec/liraglutide; Novo Nordisk) Explore Important Brand Loyalty Issues NPS+ Type 2 Diabetes Mellitus (EU5) offers valuable insight into brand loyalty from ...

... how does each of the leading brands compare to its competitors? NPS+ Type 2 Diabetes Mellitus (US) gives a unique insight into the overall brand health of ... (liraglutide; Novo Nordisk) Explore Important Brand Loyalty Issues NPS+ Type 2 Diabetes Mellitus (US) offers valuable insight into brand loyalty from the ...

... what your team gets right, and where it’s going wrong in Medical Affairs Reputations: Type 2 Diabetes Mellitus (EU5). Comparing 7 major melanoma treatments from Novo ...

Find out what the leading medical affairs teams in type 2 diabetes are doing right Medical affairs teams for several leading T2DM treatments in the US ... your team gets right, and where it’s going wrong in Medical Affairs Reputations: Type 2 Diabetes Mellitus (US). Comparing 11 major melanoma treatments from ...

... India, Pfizer India, Sanofi Aventis, Sun Pharmaceuticals, USV India. Market Segments 1. INDIAN DIABETES MARKET BY TYPE 2. INDIAN DIABETES MARKET BY DRUG CLASS 3. INDIAN DIABETES MARKET BY DEVICES OMR REPORT COVERS: Comprehensive research methodology of Global Indian Diabetes Market ...

... also included at a country level across the 10-year forecast snapshot. These gastrointestinal symptoms include: Nausea ... impact from specific co-morbid conditions on Diabetic Gastroparesis prevalent population. Identify sub-populations within Diabetic Gastroparesis which require treatment. Gain an understanding ...

... at a country level across the 10-year forecast snapshot. There are many co-morbidities associated with Type 1 Diabetes Mellitus, including: Chronic pancreatitis Cystic fibrosis Autoimmune ... on the impact from specific co-morbid conditions on Type 1 Diabetes Mellitus prevalent population. Identify sub-populations within Type 1 Diabetes Mellitus which require treatment. Gain an understanding of the ...

... at a time when growth rates in the more developed markets have declined. IMARC’s new report “China Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics” provides ...

IMARC’s new report “Japan Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics” provides an analytical and statistical insight into the Japanese diabetes market. The report provides both ...

IMARC’s new report “UK Diabetes Market Report: 2017 - 2022” provides an analytical and statistical insight into the UK diabetes market. The report provides both current and future trends in the prevalence ...

... seen during pregnancy. The report “Global Diabetes Market” provides an in-depth analysis of the global diabetes market, along with the regional markets. The major trends, growth ... profiled. The key factors driving the growth of diabetes market are growing ageing population, growing urbanization, increasing ...

... for diabetes are analyzed in this section. We also look at diabetes epidemiology. Moving to the next section, we analyze the global diabetes market through a market overview and an analysis of the market by diabetes ...

... new report “US Diabetes Market Report: 2016 - 2020” provides an analytical and statistical insight into the US diabetes market. The report ... provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in the United States ...

Market Insight Global Diabetes Market is expected to grow at a CAGR of 8.1 percent for the forecasted period of 2015-2020. The market is segmented on the basis of type of diabetes, drugs class and ...

... diabetes and pre-diabetes are found in the United States, with many still unaware about their diabetes or pre-diabetes ... diabetic drugs. The report, “US Diabetes Market Outlook 2020”, highlights the US diabetes market by each segment. The market for each segment has been thoroughly studied and the future market ...

... product to Lantus now known as Toujeo. See Physician Views Poll Results – Usage of Sanofi's U300 will not ... this point. In the oral diabetes market, there are two key trends to watch. In the GLP ... , FirstWord is polling US and EU5-based endocrinologists on five key questions ahead of the ADA meeting, Specifically ...

What market barriers are influencing the Type 2 Diabetes (T2DM) market? From price to availability to reimbursement factors, FirstView Barriers – An Analysis of Market Barriers in Type 2 Diabetes (EU5) provides insights that can help develop, shape and refine your brand strategies. Also Available is FirstView Barriers – An Analysis ...

What environmental market barriers are influencing the Type 2 Diabetes (T2DM) market? From price to availability to reimbursement factors, FirstView Barriers – An Analysis of Market Barriers in Type 2 Diabetes (US) provides insights that can help develop, shape and refine your brand strategies. Also Available is FirstView Barriers – An Analysis of Market Barriers ...

... 's Eylea). Converting any clinical advantage to the commercial setting may prove challenging, however, ... injection for Eylea. To better ascertain the impact of the Protocol T study results on uptake of Eylea, ... treatment of DME? In the first-line setting, what level of overall switching (or alternative new start ...

... and value of these teams. FirstWord's latest Physician Views poll seeks to gain some insight into how endocrinologists value the role that medical affairs ... asking US and EU5-based physicians: How important they view medical affairs teams in enabling effective communication between physicians and pharmaceutical companies? Which activities ...

... in 0-2 business days after order is placed. Netscribes’ latest market research report titled HbA1c Testing Market in India 2014 states that with the increasing incidence of diabetes ...

... term: battle lines are drawn The fundamental drivers of the global diabetes market are strong and continue to fuel growth. Rising levels ... comprehensive FirstWord research is available in two comprehensive modules: The KOL Insight: Diabetes module provides a complete review and is enhanced with exclusive ...

... diabetes care. “UAE Diabetes Market Opportunity Analysis 2018” gives comprehensive insight on following aspects related to pharmaceutical market: Market Overview Diabetes Prevalence Diabetes Drug Market Insulin Delivery Devices Market Glucose Monitoring Devices Market Diabetes Market ...

... to reach approximately US$ 4.6 Billion by 2018. In RNCOS’ latest report “China Diabetes Market Outlook 2018”, the country’s diabetes market has been segmented ... been extending their product portfolios in order to gain their own market shares. In the end, RNCOS concludes with a competitive analysis of major ...

Takeda’s late stage pipeline candidate – Vortioxetine (Filed, Partnered with Lundbeck, US PDUFA on October 2nd) is expected to get ... present an attractive market for new entrants. Reported PhIII data of Vortioxetine look. However, other pipeline candidates are chasing ...

... ; Novo Nordisk) recent US failure, the exponential market growth makes diabetes one of the most attractive opportunities in Pharma. Competition in the major ... market share from the gold standard treatments. ‘Therapy Trends: Diabetes’ is compiled from exclusive, in-depth interviews with the world’s leading ...

... run in January looking at physician detailing, this week’s FirstWord Physician Views poll investigates which companies are best at physician marketing in the diabetes space. Notably, failure to gain ... endocrinologists, which are the best detailing diabetes companies and drugs and what factors support this view. This week's FirstWord Physician Views poll will ...

... to extend and enhance its market-leading Lantus franchise. At the ADA meeting, Sanofi released the first Phase III data for ... patent expiry date is feasible. In light of recent developments, this week’s Physician Views poll will ask US-based endocrinologists: Whether they anticipate data ...

... of pharmaceutical manufacturers, this week's Physician Views poll will seek feedback from US-based endocrinologists on three key recent developments – discussion regarding pancreatic cancer/pancreatitis ... Physicians View poll will ask US-based endocrinologists: How their prescribing of DPP-4 and GLP-1 products may shift in light of the FDA’s recent assessment ...

... growth rates in the more developed markets have declined. IMARC’s new report “Indian Diabetes Market Report: Epidemiology, Patients, Prevalence, Oral Anti- ... , demographical breakup, diagnosis and treatment of diabetes in India. The report has segmented the Indian diabetes market into three segments

... refractory patients– each of these segments carries ~$1b opportunity to Takeda. In this report, we have analyze TAK-875 market positioning and model, target segments, therapy ...

Turn of The Decade: Novel Glp-1’s To Emerge as the New Leader in Diabetes Class Bydureon – A near term growth driver of the class Novel delivery platforms and fixed ... in cumulative peak sales for this class of drugs by the turn of this decade as we see innovation efforts around this class will result in ...

Single User PDF Format: US$ 800.00 Multi-User License: US$ 1,200.00 Hard Copy: US$ 900.00 CD-ROM: US$ 900.00 Diabetes has emerged as one of the most common diseases in China, affecting...

IMARC’s new report “Japan Diabetes Market Report & Forecast 2011-2016” provides an analytical and statistical insight into the Japanese diabetes market. The report provides both current and future tre...

Product description The present Competitive Intelligence Report about Targeted Therapy of Diabetes provides a competitor evaluation in the field of novel molecules being developed for treatment of type 1 and 2 diabetes as of April 2011. Major pharmacologic approaches include insulin, PPAR agonists, DPP-IV ...

Single User PDF Format: US$ 800.00 Multi-User License: US$ 1,200.00 Hard Copy: US$ 900.00 CD-ROM: US$ 900.00 Diabetes is the world’s most costly epidemic. It is anticipated that, over...

As the second largest economy of the world, China enjoys pink of health but its affluence is giving rise to another sickness- a rapid increase in a life-style disease called diabetes. With the Chinese...